Healthcare Tips: FDA approves Shire's keenly-watched eye drug

(Reuters) - The U.S. Food and Drug Administration on Monday approved Shire Plc's lifitegrast eye drops for treating signs and symptoms of dry eye disease, allowing the company to bring to market its most important pipeline medicine.

Read more: FDA approves Shire's keenly-watched eye drug